v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Preferred Stock
Series Seed Preferred Stock
Preferred Stock
Series A preferred stock
Preferred Stock
Series A-2 Preferred Stock
Preferred Stock
Series A-3 Preferred Stock
Preferred Stock
Series CF Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series A Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance (in shares) at Dec. 31, 2019 20,714,518 5,654,072 5,932,742 8,223,036 126,641     6,642      
Beginning balance at Dec. 31, 2019 $ 2,071 $ 565 $ 593 $ 823 $ 12     $ 1 $ 15,486,115 $ (22,617,702) $ (7,150,199)
Offering costs                 (69,470)   (69,470)
Stock-based compensation                 144,775   144,775
Net loss                   (10,728,295) (10,728,295)
Ending balance at Dec. 31, 2020 $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075   $ 1 27,482,060 (33,345,997) (5,857,645)
Ending balance (in shares) at Dec. 31, 2020 20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717   6,642      
Conversion of preferred stock into common stock               $ 1 27,519,036    
Stock-based compensation                 36,976   36,976
Net loss                   (3,023,935) (3,023,935)
Ending balance at Mar. 31, 2021 $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075       (36,369,932) (8,844,604)
Ending balance (in shares) at Mar. 31, 2021 20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717   6,642      
Beginning balance (in shares) at Dec. 31, 2020 20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717   6,642      
Beginning balance at Dec. 31, 2020 $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075   $ 1 27,482,060 (33,345,997) (5,857,645)
Conversion of preferred stock into common stock                     6,293
Conversion of debt into common stock                     2,680,289
Issuance of common stock pursuant to equity line of credit                     367,996
Net loss                     (22,659,480)
Ending balance at Sep. 30, 2021               $ 11 57,468,268 (56,005,477) 1,462,801
Ending balance (in shares) at Sep. 30, 2021               126,275      
Beginning balance (in shares) at Dec. 31, 2020 20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717   6,642      
Beginning balance at Dec. 31, 2020 $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075   $ 1 27,482,060 (33,345,997) (5,857,645)
Conversion of preferred stock into common stock $ (2,071) $ (565) $ (593) $ (904) $ (83) $ (2,075)   $ 4 6,287   6,291
Conversion of preferred stock into common stock (shares) (20,714,518) (5,654,072) (5,932,742) (9,032,330) (836,331) (20,754,717)   40,272      
Issuance of common stock in public offering               $ 2 10,000,000   10,000,002
Issuance of common stock in public offering (in shares)               24,096      
Offering costs                 (2,116,957)   (2,116,957)
Exercise of over-allotment option, net of offering costs                 1,364,997   1,364,997
Exercise of over-allotment option, net of offering costs (in shares)               3,614      
Conversion of debt into common stock               $ 1 2,680,288   2,680,289
Conversion of debt into common stock (In shares)               11,352      
Conversion of related party notes and payables into common stock                 257,515   257,515
Conversion of related party notes and payables into common stock (in shares)               1,524      
Common stock and warrants issued in connection with note                 501,658   501,658
Common stock and warrants issued in connection with note (in shares)               1,300      
Common stock issued in connection with business combination               $ 3 11,428,735   11,428,738
Common stock issued in connection with business combination (in shares)               32,943      
Exercise of warrants                 1,768,046   1,768,046
Exercise of warrants (in shares)               3,869      
Common stock issued pursuant to consulting agreement                 595,500   595,500
Common stock issued pursuant to consulting agreement (in shares)               2,415      
Issuance of common stock pursuant to equity line of credit                 367,696   367,696
Stock-based compensation                 4,278,337   4,278,337
Stock-based compensation (Shares)               727      
Net loss                   (32,357,957) (32,357,957)
Ending balance at Dec. 31, 2021               $ 13 58,614,160 (65,703,954) (7,089,781)
Ending balance (in shares) at Dec. 31, 2021               130,017      
Beginning balance (in shares) at Mar. 31, 2021 20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717   6,642      
Beginning balance at Mar. 31, 2021 $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075       (36,369,932) (8,844,604)
Conversion of preferred stock into common stock $ (2,071) $ (565) $ (593) $ (904) $ (83) $ (2,075)   $ 4 6,287    
Conversion of preferred stock into common stock (shares) (20,714,518) (5,654,072) (5,932,742) (9,032,330) (836,331) (20,754,717)   40,272      
Issuance of common stock in public offering               $ (2) (10,000,000)   (10,000,002)
Issuance of common stock in public offering (in shares)               24,096      
Offering costs                 (2,116,957)   (2,116,957)
Exercise of over-allotment option, net of offering costs                 1,364,997   1,364,997
Exercise of over-allotment option, net of offering costs (in shares)               3,614      
Conversion of debt into common stock               $ 1 2,680,288   2,680,289
Conversion of related party notes and payables into common stock                 257,515   257,515
Conversion of related party notes and payables into common stock (in shares)               1,524      
Common stock and warrants issued in connection with note                 73,958   73,958
Common stock and warrants issued in connection with note (in shares)               200      
Common stock issued in connection with business combination               $ 2 8,025,540   8,025,542
Common stock issued in connection with business combination (in shares)               21,928      
Exercise of warrants                 145,696   145,696
Exercise of warrants (in shares)               319      
Common stock issued pursuant to consulting agreement                 183,000   183,000
Common stock issued pursuant to consulting agreement (in shares)               500      
Stock-based compensation                 3,801,553   3,801,553
Net loss                   (10,697,498) (10,697,498)
Conversion of notes into common stock (in shares)               11,352      
Ending balance at Jun. 30, 2021               $ 10 51,940,914 (47,067,430) 4,873,493
Ending balance (in shares) at Jun. 30, 2021               110,446      
Issuance of common stock in public offering                 367,696   367,696
Issuance of common stock in public offering (in shares)               1,264      
Common stock issued in connection with business combination               $ 1 3,403,195   3,403,196
Common stock issued in connection with business combination (in shares)               11,015      
Exercise of warrants                 1,622,350   1,622,350
Exercise of warrants (in shares)               3,550      
Stock-based compensation                 134,113   134,113
Net loss                   (8,938,047) (8,938,047)
Ending balance at Sep. 30, 2021               $ 11 57,468,268 (56,005,477) 1,462,801
Ending balance (in shares) at Sep. 30, 2021               126,275      
Beginning balance (in shares) at Dec. 31, 2021               130,017      
Beginning balance at Dec. 31, 2021               $ 13 58,614,160 (65,703,954) (7,089,781)
Stock-based compensation                 139,093   139,093
Net loss                   (7,832,942) (7,832,942)
Conversion of notes into common stock               $ 1 1,201,581   1,201,582
Conversion of notes into common stock (in shares)               8,739      
Ending balance at Mar. 31, 2022               $ 14 59,954,834 (73,536,896) (13,582,048)
Ending balance (in shares) at Mar. 31, 2022               138,756      
Beginning balance (in shares) at Dec. 31, 2021               130,017      
Beginning balance at Dec. 31, 2021               $ 13 58,614,160 (65,703,954) (7,089,781)
Conversion of debt into common stock                     1,802,372
Net loss                     (22,261,338)
Ending balance at Sep. 30, 2022             $ 1 $ 53 75,440,940 (87,965,292) (12,524,298)
Ending balance (in shares) at Sep. 30, 2022   1         6,300 529,492      
Beginning balance (in shares) at Mar. 31, 2022               138,756      
Beginning balance at Mar. 31, 2022               $ 14 59,954,834 (73,536,896) (13,582,048)
Issuance of common stock in public offering               $ (37) (9,347,413)   (9,347,450)
Issuance of common stock in public offering (in shares)               373,898      
Offering costs                 (1,930,486)   (1,930,486)
Stock-based compensation                 119,759   119,759
Net loss                   (9,533,924) (9,533,924)
Conversion of notes and derivative liability into common stock               $ 2 600,788   600,790
Conversion of notes and derivative liability into common stock (in shares)               16,088      
Warrants issued in connection with note                 98,241   98,241
Ending balance at Jun. 30, 2022               $ 53 68,190,549 (83,070,820) (14,880,218)
Ending balance (in shares) at Jun. 30, 2022               528,742      
Common stock issued pursuant to consulting agreement                 123,000   123,000
Common stock issued pursuant to consulting agreement (in shares)               750      
Stock-based compensation                 110,093   110,093
Net loss                   (4,894,472) (4,894,472)
Warrants issued in connection with note                 692,299   692,299
Issuance of Series A preferred stock                 25,000   25,000
Issuance of Series A preferred stock (in shares)   1                  
Conversion of venture debt into Series A convertible preferred stock             $ 1   6,299,999   6,300,000
Conversion of venture debt into Series A convertible preferred stock (in shares)             6,300        
Ending balance at Sep. 30, 2022             $ 1 $ 53 $ 75,440,940 $ (87,965,292) $ (12,524,298)
Ending balance (in shares) at Sep. 30, 2022   1         6,300 529,492